126 related articles for article (PubMed ID: 38344808)
101. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma.
Wu DH; Jia CC; Chen J; Lin ZX; Ruan DY; Li X; Lin Q; Min-Dong ; Ma XK; Wan XB; Cheng N; Chen ZH; Xing YF; Wu XY; Wen JY
Tumour Biol; 2014 Dec; 35(12):12225-33. PubMed ID: 25256671
[TBL] [Abstract][Full Text] [Related]
102. Mitotic Centromere-Associated Kinesin (MCAK/KIF2C) Regulates Cell Migration and Invasion by Modulating Microtubule Dynamics and Focal Adhesion Turnover.
Moon HH; Kreis NN; Friemel A; Roth S; Schulte D; Solbach C; Louwen F; Yuan J; Ritter A
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830827
[TBL] [Abstract][Full Text] [Related]
103. Functional characterization of MCAK/Kif2C cancer mutations using high-throughput microscopic analysis.
Wagenbach M; Vicente JJ; Ovechkina Y; Domnitz S; Wordeman L
Mol Biol Cell; 2020 Mar; 31(7):580-588. PubMed ID: 31746663
[TBL] [Abstract][Full Text] [Related]
104. Involvement of kinesin family member 2C/mitotic centromere-associated kinesin overexpression in mammary carcinogenesis.
Shimo A; Tanikawa C; Nishidate T; Lin ML; Matsuda K; Park JH; Ueki T; Ohta T; Hirata K; Fukuda M; Nakamura Y; Katagiri T
Cancer Sci; 2008 Jan; 99(1):62-70. PubMed ID: 17944972
[TBL] [Abstract][Full Text] [Related]
105. Multi-omics analysis of kinesin family member 2C in human tumors: novel prognostic biomarker and tumor microenvironment regulator.
Zhang B; Liu P; Li Y; Hu Q; Li H; Pang X; Wu H
Am J Cancer Res; 2022; 12(11):4954-4976. PubMed ID: 36504885
[TBL] [Abstract][Full Text] [Related]
106. KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.
Kreis NN; Moon HH; Wordeman L; Louwen F; Solbach C; Yuan J; Ritter A
Crit Rev Clin Lab Sci; 2024 Feb; ():1-31. PubMed ID: 38344808
[TBL] [Abstract][Full Text] [Related]
107. KIF2C: An important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesis.
Li RQ; Yang Y; Qiao L; Yang L; Shen DD; Zhao XJ
Biomed Pharmacother; 2024 Feb; 171():116173. PubMed ID: 38237349
[TBL] [Abstract][Full Text] [Related]
108. Molecular insight into the regulation and function of MCAK.
Ritter A; Kreis NN; Louwen F; Wordeman L; Yuan J
Crit Rev Biochem Mol Biol; 2015; 51(4):228-45. PubMed ID: 27146484
[TBL] [Abstract][Full Text] [Related]
109. Mitotic centromere-associated kinesin (MCAK): a potential cancer drug target.
Sanhaji M; Friel CT; Wordeman L; Louwen F; Yuan J
Oncotarget; 2011 Dec; 2(12):935-47. PubMed ID: 22249213
[TBL] [Abstract][Full Text] [Related]
110. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
111. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
112. The prognostic value and mechanisms of lncRNA UCA1 in human cancer.
Yao F; Wang Q; Wu Q
Cancer Manag Res; 2019; 11():7685-7696. PubMed ID: 31616184
[TBL] [Abstract][Full Text] [Related]
113.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
114.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
115.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
